COSMOS Pharmaceutical Revenue vs. Current Valuation

Please note, there is a significant difference between COSMOS Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if COSMOS Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSMOS Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

COSMOS Pharmaceutical Current Valuation vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining COSMOS Pharmaceutical's current stock value. Our valuation model uses many indicators to compare COSMOS Pharmaceutical value to that of its competitors to determine the firm's financial worth.
COSMOS Pharmaceutical is the top company in revenue category among its peers. It is rated below average in current valuation category among its peers reporting about  0.01  of Current Valuation per Revenue. The ratio of Revenue to Current Valuation for COSMOS Pharmaceutical is roughly  193.99 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the COSMOS Pharmaceutical's earnings, one of the primary drivers of an investment's value.

COSMOS Revenue vs. Competition

COSMOS Pharmaceutical is the top company in revenue category among its peers. Market size based on revenue of Pharmaceutical Retailers industry is currently estimated at about 2.53 Trillion. COSMOS Pharmaceutical totals roughly 755.41 Billion in revenue claiming about 30% of equities listed under Pharmaceutical Retailers industry.

COSMOS Current Valuation vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

COSMOS Pharmaceutical

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
755.41 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

COSMOS Pharmaceutical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
3.89 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

COSMOS Current Valuation vs Competition

COSMOS Pharmaceutical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Pharmaceutical Retailers industry is currently estimated at about (41.3 Billion). COSMOS Pharmaceutical adds roughly 3.89 Billion in current valuation claiming only tiny portion of equities listed under Pharmaceutical Retailers industry.

COSMOS Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on COSMOS Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of COSMOS Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the COSMOS Pharmaceutical's important profitability drivers and their relationship over time.

COSMOS Pharmaceutical Earnings per Share Projection vs Actual

Use COSMOS Pharmaceutical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if COSMOS Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSMOS Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

COSMOS Pharmaceutical Pair Trading

COSMOS Pharmaceutical Pair Trading Analysis

The ability to find closely correlated positions to BlackRock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BlackRock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BlackRock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BlackRock to buy it.
The correlation of BlackRock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BlackRock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BlackRock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BlackRock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your COSMOS Pharmaceutical position

In addition to having COSMOS Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Long/short ETFs Thematic Idea Now

Long/short ETFs
Long/short ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in COSMOS Pink Sheet

If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules